author-photo

Stephanie Noviello

Bristol-Myers Squibb
Schering-Plough

88

Papers

5021

Citations

Citation Trend

Filter By

Papers (88) Sort By

Journal Conference Others

Factors to Consider in Development of Drugs for Pediatric Nonalcoholic Fatty Liver Disease

2019 Gastroenterology
Show All
- Source
- Cite
- Save
Citations (8)
Long-term follow-up of clinical trial patients treated for chronic HCV infection with daclatasvir-based regimens

2018 Liver International
Show All
- Source
- Cite
- Save
Citations (17)
Potent viral suppression and improvements in alpha-fetoprotein and measures of fibrosis in Japanese patients receiving a daclatasvir/asunaprevir/beclabuvir fixed-dose combination for the treatment of HCV genotype-1 infection

2018 Journal of Gastroenterology
Show All
- Source
- Cite
- Save
Citations (1)
Daclatasvir plus asunaprevir in treatment-naïve patients with hepatitis C virus genotype 1b infection

2018 World Journal of Gastroenterology
Show All
- Source
- Cite
- Save
Citations (5)
Pegbelfermin (BMS-986036), a PEGylated fibroblast growth factor 21 analogue, in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 2a trial

2018 The Lancet
Show All
- Source
- Cite
- Save
Citations (197)
BMS-986036 (pegylated FGF21) in patients with non-alcoholic steatohepatitis: a phase 2 study

2017 Journal of Hepatology
Show All
- Source
- Cite
- Save
Citations (23)
Long-term Follow-up of Children Treated With Peginterferon and Ribavirin for Hepatitis C Virus Infection.

2017 Journal of Pediatric Gastroenterology and Nutrition
Show All
- Source
- Cite
- Save
Citations (9)
Efficacy and safety of daclatasvir plus pegylated-interferon alfa 2a and ribavirin in previously untreated HCV subjects coinfected with HIV and HCV genotype-1: a Phase III, open-label study

2017 Hepatology International
Show All
- Source
- Cite
- Save
Citations (3)
PO-066 : A Long-Term, Observational, Follow-Up Study of Patients Treated in Phase 2 and 3 Clinical Studies with Daclatasvir- Based Regimens: Efficacy and Safety Outcomes

2017
Show All
- Source
- Cite
- Save
Citations (2)
Daclatasvir with sofosbuvir and ribavirin for hepatitis C virus infection with advanced cirrhosis or post-liver transplantation recurrence

2016 Hepatology
Show All
- Source
- Cite
- Save
Citations (351)